IFIH1 and dermatomyositis: Clinically, anti-MDA5 dermatomyositis is a distinct subtype of inflammatory myopathy characterized by the presence of autoantibodies against MDA5 and is frequently associated with a high risk of rapidly progressive interstitial lung disease.